OPHTHALMOLOGY PACS MARKET ANALYSIS

A picture archiving and communication system (PACS) is a therapeutic imaging technology that provides storage and useful access to images in numerous manner. Ophthalmology PACS is used to transfer or communicate electrical images and reports at different places. This removes the need to physically file, recover, or transport film jackets, the files used to store and protect X-ray film.

• With ophthalmology PACS, medical images of patients with eye diseases are taken and studied for medical examination, findings, and treatment. The evidence collected can be used to classify any structural and physical abnormalities.
• The increasing prevalence of eye diseases globally is expected to increase the demand  ophthalmology PACS worldwide.
• Ophthalmology PACS is used to store medical documents and pictures securely in off-site servers and be securely opened from anywhere in the world using PACS software, portable devices, etc.

Global Ophthalmology PACS Market - Impact of the Coronavirus (COVID-19) Pandemic

The COVID-19 pandemic is expected to hamper the growth of the global ophthalmology PACS market owing to a decline in patient’s clinical visits. For instance, according to the data published on December 2, 2021 by the National Institute of Heath, U.S., the COVID-19 pandemic has adversely affected admission to eye care clinics due to travel limitations, unemployment-related financial challenges, fear of infection, etc. There was an extreme decline in clinic visits and procedures which is expected to hamper the growth of the global ophthalmology PACS market.

Moreover, a decline in eye disease treatment during COVID-19 is expected to hamper the global ophthalmology PACS market growth. For instance, according to the data published in July 2020 in the Indian Journal of Ophthalmology, the COVID-19 pandemic has a huge negative impact on the working of eye-care hospitals. The lockdown has put a burden on patients, clinicians, staff, and the hospital management. COVID-19 pandemic and government-imposed restrictions have brought financial, logistic, and psychological challenges. This made reduction of visit of patient to eye clinics and hospitals this resulted into decline in eye treatment which is expected to hamper the growth of global ophthalmology PACS market.

The global ophthalmology PACS market is estimated to be valued at US$ 201.18 Mn in 2022 and is expected to exhibit a CAGR of 5.9% over the forecast period (2022-2030).

Figure 1: Global Ophthalmology PACS Market Share, (%), Analysis, By Type, 2022

To learn more about this report, request a free sample copy

Market players are involved in signing agreements with other key players, in order to expand their services. This is expected to drive the growth of the global ophthalmology PACS market over the forecast period.

Market players are involved in signing agreements and this is expected to drive growth of the global ophthalmology PACS market over the forecast period. For instance, in July 2018, IBM, a technology company, announced an agreement with Anthem Inc., a healthcare company, for the expansion of service agreement to drive the digital transformation and deliver an improved digital experience to healthcare consumers. According to the agreement, IBM had provided Anthem with initiative services for its mainframe, data center server, and storage infrastructure management. The growth of digital transformation in the healthcare sector is expected to drive the global ophthalmology PACS market growth. 

Key players are engaged in receiving approvals for their products from regulatory authorities, and this is expected to drive the growth of the global ophthalmology PACS market over the forecast period.

Product approvals by regulatory bodies is expected to drive the growth of the global ophthalmology PACS market over the forecast period. For instance, on April 20, 2022, Carl Zeiss Sports Optics, a technology enterprise operating in the fields of optics and optoelectronics, announced that it received approval for QUATERA 700 from the U.S. Food and Drug Administrator. QUATERA 700 was made to develop a surgeon’s workflow effectiveness from the clinic to the operating room, allowing one digitally integrated surgical workflow. It works as a single sterile operating room dashboard integrating patient data from other systems and the microscope view. 

Global Ophthalmology PACS Market – Restraints

An increasing number of product recalls is expected to hamper the growth of the global ophthalmology PACS market over the forecast period. For instance, on March 13, 2017, Merge Healthcare, Inc., a provider of digital solution for healthcare, had recalled Class 2 Device, Merge Eye Care Systems, which consist of Merge Eye Station, Merge Eye Care PACS, and Merge Eye Station Import Utility. The system was recalled as it completely stopped allowing the downloading or acquisition of new images due to incompatible software application versions. This is expected to hamper the growth of the global ophthalmology PACS market. 

Global Ophthalmology PACS Market – Regional Analysis

On the basis of region, the global ophthalmology PACS market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa.

Among regions, the North America ophthalmology PACS market is expected to hold a dominant position during the forecast period, owing to increasing inorganic activities such as acquisition by key players. For instance, in August 2017, Carl Zeiss Meditec Inc., a U.S.-based medical technology manufacturer, acquired Veracity Innovations, LLC, a medical software company which provides cloud-based platforms to its customers for increased medical performance. The acquisition was aimed at increasing the Carl Zeiss Meditec’s eye care-based digital solution collection. These software had supported ophthalmologists in bringing modified technology-empowered care to their patients.

Furthermore, India is estimated to witness significant growth in the global ophthalmology PACS market, owing to the increasing prevalence of eye disease in the country. For instance, according to the data published in February 2018 by the National Institute of Health, U.S., the prevalence of dry eye disease in India was up to 54.3%, as compared with the global prevalence of dry eye disease. Increase prevalence of dry eye disease is expected to drive the ophthalmology PACS market growth.

Figure 2: Global Ophthalmology PACS Market (US$ Mn), by Region, 2022

To learn more about this report, request a free sample copy

Global Ophthalmology PACS Market – Competitive Landscape

Major players operating in the global ophthalmology PACS market include Topcon Corporation, Agfa-Gevaert N.V., Sonomed Escalon, Carl Zeiss Meditec AG, EyePACS, VersaSuite, Heidelberg Engineering GmbH, ScImage, Inc., IBM Corporation, and Visbion Limited.